FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia

Listens: 0

About

FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia FDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia.

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

February 27, 2020

Science

FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia FDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia.